Top Health Care companies in United States by EBITDA

This ranking features the top 729 Health Care companies in United States ranked by EBITDA, totalling a EBITDA of USD 285.10 B, for January 15, 2025.

United States

Health Care

#	Name	EBITDA	Reported Date	Stock Price	Change	Country
1	Johnson & Johnson 1 JNJ	USD 29.51 B	Sept. 29, 2024	USD 144.75	0.19%	United States
2	UnitedHealth Group Incorporated 2 UNH	USD 26.73 B	Sept. 30, 2024	USD 543.74	0.48%	United States
3	AbbVie Inc. 3 ABBV	USD 24.24 B	Sept. 30, 2024	USD 175.55	-0.67%	United States
4	Merck & Co., Inc. 4 MRK	USD 19.17 B	Sept. 30, 2024	USD 99.65	-1.32%	United States
5	CVS Health Corporation 5 CVS	USD 14.20 B	Sept. 30, 2024	USD 51.57	0.10%	United States
6	HCA Healthcare, Inc. 6 HCA	USD 13.96 B	Sept. 30, 2024	USD 305.79	-0.78%	United States
7	Pfizer Inc. 7 PFE	USD 13.84 B	Sept. 29, 2024	USD 26.41	-1.46%	United States
8	Amgen Inc. 8 AMGN	USD 13.05 B	Sept. 30, 2024	USD 267.10	-1.14%	United States
9	Eli Lilly and Company 9 LLY	USD 12.51 B	Sept. 30, 2024	USD 744.91	-6.59%	United States
10	Thermo Fisher Scientific Inc. 10 TMO	USD 11.31 B	Sept. 28, 2024	USD 556.99	0.27%	United States
11	Elevance Health Inc. 11 ELV	USD 10.82 B	Sept. 30, 2024	USD 393.16	-0.84%	United States
12	Abbott Laboratories 12 ABT	USD 10.76 B	Sept. 30, 2024	USD 113.02	-0.15%	United States
13	Cigna Corporation 13 CI	USD 9.32 B	Sept. 30, 2024	USD 285.03	0.91%	United States
14	Danaher Corporation 14 DHR	USD 7.16 B	Sept. 27, 2024	USD 237.62	-0.94%	United States
15	Centene Corporation 15 CNC	USD 5.89 B	Sept. 30, 2024	USD 63.40	-0.47%	United States
16	Stryker Corporation 16 SYK	USD 5.48 B	Sept. 30, 2024	USD 362.80	0.50%	United States
17	Bristol-Myers Squibb Company 17 BMY	USD 5.06 B	Sept. 30, 2024	USD 55.74	0.69%	United States
18	Regeneron Pharmaceuticals, Inc. 18 REGN	USD 4.83 B	Sept. 30, 2024	USD 690.87	-3.63%	United States
19	McKesson Corporation 19 MCK	USD 4.82 B	Sept. 30, 2024	USD 593.73	1.48%	United States
20	Tenet Healthcare Corporation 20 THC	USD 4.30 B	Sept. 30, 2024	USD 127.63	-1.27%	United States
21	Becton, Dickinson and Company 21 BDX	USD 4.26 B	Sept. 30, 2024	USD 235.80	-0.17%	United States
22	Gilead Sciences, Inc. 22 GILD	USD 3.92 B	Sept. 30, 2024	USD 91.00	1.18%	United States
23	Zoetis Inc. 23 ZTS	USD 3.85 B	Sept. 30, 2024	USD 164.41	-1.15%	United States
24	Humana Inc. 24 HUM	USD 3.77 B	Sept. 30, 2024	USD 282.63	-1.65%	United States
25	Boston Scientific Corporation 25 BSX	USD 3.73 B	Sept. 30, 2024	USD 95.65	1.10%	United States
26	GE HealthCare Technologies Inc. 26 GEHC	USD 3.58 B	Sept. 30, 2024	USD 84.13	-1.40%	United States
27	Albertsons Companies, Inc. 27 ACI	USD 3.43 B	Nov. 30, 2024	USD 20.73	0.34%	United States
28	Cencora 28 COR	USD 3.33 B	Sept. 30, 2024	USD 240.05	1.68%	United States
29	IQVIA Holdings Inc. 29 IQV	USD 3.23 B	Sept. 30, 2024	USD 197.96	-3.26%	United States
30	Biogen Inc. 30 BIIB	USD 2.90 B	Sept. 30, 2024	USD 143.06	-4.74%	United States
31	DaVita Inc. 31 DVA	USD 2.60 B	Sept. 30, 2024	USD 162.00	3.15%	United States
32	Cardinal Health, Inc. 32 CAH	USD 2.57 B	Sept. 30, 2024	USD 124.03	2.62%	United States
33	Viatris Inc. 33 VTRS	USD 2.51 B	Sept. 30, 2024	USD 11.72	-0.68%	United States
34	Zimmer Biomet Holdings, Inc. 34 ZBH	USD 2.51 B	Sept. 30, 2024	USD 104.71	-0.74%	United States
35	Intuitive Surgical, Inc. 35 ISRG	USD 2.51 B	Sept. 30, 2024	USD 538.88	-0.16%	United States
36	Royalty Pharma plc 36 RPRX	USD 2.15 B	Sept. 30, 2024	USD 30.03	0.13%	United States
37	Universal Health Services, Inc. 37 UHS	USD 2.13 B	Sept. 30, 2024	USD 184.16	-0.85%	United States
38	AMETEK, Inc. 38 AME	USD 2.11 B	Sept. 30, 2024	USD 179.15	1.50%	United States
39	Baxter International Inc. 39 BAX	USD 1.92 B	Sept. 30, 2024	USD 30.62	0.39%	United States
40	Molina Healthcare, Inc. 40 MOH	USD 1.82 B	Sept. 30, 2024	USD 294.03	-0.14%	United States
41	Solventum Corporation 41 SOLV	USD 1.79 B	Sept. 30, 2024	USD 70.19	2.45%	United States
42	Agilent Technologies, Inc. 42 A	USD 1.73 B	Oct. 31, 2024	USD 143.43	1.04%	United States
43	Edwards Lifesciences Corporation 43 EW	USD 1.70 B	Sept. 30, 2024	USD 71.04	-0.07%	United States
44	Organon & Co. 44 OGN	USD 1.69 B	Sept. 30, 2024	USD 15.81	0.96%	United States
45	ResMed Inc. 45 RMD	USD 1.69 B	Sept. 30, 2024	USD 228.83	-0.62%	United States
46	Inhibrx Biosciences, Inc. 46 INBX	USD 1.66 B	Sept. 30, 2024	USD 12.74	-6.60%	United States
47	Lincoln National Corporation 47 LNC	USD 1.53 B	Sept. 30, 2024	USD 31.49	2.37%	United States
48	United Therapeutics Corporation 48 UTHR	USD 1.51 B	Sept. 30, 2024	USD 364.70	0.50%	United States
49	Laboratory Corporation of America Holdings 49 LH	USD 1.41 B	Sept. 30, 2024	USD 234.50	0.17%	United States
50	Hologic, Inc. 50 HOLX	USD 1.30 B	Sept. 28, 2024	USD 70.20	-0.13%	United States

1 2 3 4 … 15

Frequently Asked Questions

Which Health Care company in United States has the highest EBITDA ?

The Health Care company in United States with the highest EBITDA is Johnson & Johnson (NYSE: JNJ) at USD 29.51 B.
Which Health Care company in United States has the lowest EBITDA ?

The Health Care company in United States with the lowest EBITDA is Walgreens Boots Alliance, Inc. (NasdaqGS: WBA) at USD -12.13 B.

What are the top 10 Health Care companies in United States by EBITDA ?

The top 10 Health Care companies in United States by EBITDA are Johnson & Johnson, UnitedHealth Group Incorporated, AbbVie Inc., Merck & Co., Inc., CVS Health Corporation, HCA Healthcare, Inc., Pfizer Inc., Amgen Inc., Eli Lilly and Company and Thermo Fisher Scientific Inc..
What are the bottom 10 Health Care companies in United States by EBITDA ?

The bottom 10 Health Care companies in United States by EBITDA are Walgreens Boots Alliance, Inc., Moderna, Inc., Heart Test Laboratories, Inc., Monopar Therapeutics Inc., QuidelOrtho Corporation, Envista Holdings Corp, Illumina, Inc., MultiPlan Corporation, Biohaven Pharmaceutical Holding Company Ltd. and Insmed Incorporated.